117 “Arming” the Chimeric Oncolytic Adenovirus Enadenotucirev to Deliver Checkpoint Inhibitors and Other Therapeutics Directly to Tumours
European Journal of Cancer - United Kingdom
doi 10.1016/s0959-8049(14)70243-6
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV